Literature DB >> 2249724

Acute upper respiratory tract viral illness and influenza immunization in homes for the elderly.

K G Nicholson1, D J Baker, A Farquhar, D Hurd, J Kent, S H Smith.   

Abstract

Occupants of 482 long-stay and 33 short-stay beds in 11 Leicester City Council homes for the elderly were studied during a 30-week period from September 1988 to March 1989 to determine the incidence, aetiology, morbidity, and mortality of acute upper respiratory tract viral infections and the use of influenza vaccine. Influenza immunization rates by home ranged from 15.4 to 90% (mean 45%). There were no differences in the distribution of medical conditions by home. The highest immunization rates were seen in people with chest disease (77%), heart disease (60%), diabetes (56%), and those with three medical conditions (75%). There was an average of 0.7 upper respiratory episodes per bed per annum with a mortality of 3.4% (6/179). Half of all episodes were seen by a general medical practitioner and 81 of 90 (90%) referrals were prescribed antibiotics costing approximately 7.50 pounds per patient. Lower respiratory tract complications developed during 45 (25%) of 179 episodes including 3 of 12 coronavirus infections, 3 of 9 respiratory syncytial virus infections, 2 of 4 adenovirus infections, 1 of 11 rhinovirus infections, but none of 5 influenza infections. Respiratory infections were caused mostly by pathogens other than influenza virus during the influenza period documented nationally. This highlights the role of coronaviruses, respiratory syncytial virus, and unidentified agents in the elderly, and questions the assumptions made in American estimates on the impact of influenza and the value of influenza vaccines.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2249724      PMCID: PMC2271825          DOI: 10.1017/s0950268800048251

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  20 in total

1.  Observations on excess mortality associated with epidemic influenza.

Authors:  T C EICKHOFF; I L SHERMAN; R E SERFLING
Journal:  JAMA       Date:  1961-06-03       Impact factor: 56.272

2.  Evaluation of influenza vaccine in an explosive epidemic of mixed etiology.

Authors:  J E SALK; A J RAPALSKI
Journal:  U S Armed Forces Med J       Date:  1958-04

3.  Excess mortality from epidemic influenza, 1957-1966.

Authors:  J Housworth; A D Langmuir
Journal:  Am J Epidemiol       Date:  1974-07       Impact factor: 4.897

Review 4.  Serious morbidity and mortality associated with influenza epidemics.

Authors:  W P Glezen
Journal:  Epidemiol Rev       Date:  1982       Impact factor: 6.222

5.  Effects of vaccination on an influenza epidemic in a geriatric hospital.

Authors:  C Sérié; M Barme; C Hannoun; M Thibon; H Beck; J P Aquino
Journal:  Dev Biol Stand       Date:  1977 Jun 1-3

6.  Enzyme-linked immunosorbent assay for detection of antibody in volunteers experimentally infected with human coronavirus strain 229 E.

Authors:  C A Kraaijeveld; S E Reed; M R Macnaughton
Journal:  J Clin Microbiol       Date:  1980-10       Impact factor: 5.948

Review 7.  Antiviral therapy. Respiratory infections, genital herpes, and herpetic keratitis.

Authors:  K G Nicholson
Journal:  Lancet       Date:  1984-09-15       Impact factor: 79.321

8.  A study of respiratory infections in the elderly to assess the role of respiratory syncytial virus.

Authors:  F Morales; M A Calder; J M Inglis; P S Murdoch; J Williamson
Journal:  J Infect       Date:  1983-11       Impact factor: 6.072

9.  Influenza vaccination of the elderly: perceptions and policies of general practitioners and outcome of the 1985-86 immunization programme in Trent, UK.

Authors:  K G Nicholson; M J Wiselka; A May
Journal:  Vaccine       Date:  1987-12       Impact factor: 3.641

10.  Pneumonia and influenza deaths during epidemics: implications for prevention.

Authors:  W H Barker; J P Mullooly
Journal:  Arch Intern Med       Date:  1982-01
View more
  25 in total

1.  Surveillance for outbreaks of respiratory tract infections in nursing homes.

Authors:  M Loeb; A McGeer; M McArthur; R W Peeling; M Petric; A E Simor
Journal:  CMAJ       Date:  2000-04-18       Impact factor: 8.262

Review 2.  Does influenza immunisation cause exacerbations of chronic airflow obstruction or asthma?

Authors:  J M Watson; J F Cordier; K G Nicholson
Journal:  Thorax       Date:  1997-02       Impact factor: 9.139

3.  Respiratory syncytial virus infection in older adults: an under-recognized problem.

Authors:  Angela R Branche; Ann R Falsey
Journal:  Drugs Aging       Date:  2015-04       Impact factor: 3.923

Review 4.  Management of community acquired lower respiratory tract infection.

Authors:  H S Hosker; G M Jones; P Hawkey
Journal:  BMJ       Date:  1994-03-12

5.  Impact of influenza and respiratory syncytial virus on mortality in England and Wales from January 1975 to December 1990.

Authors:  K G Nicholson
Journal:  Epidemiol Infect       Date:  1996-02       Impact factor: 2.451

Review 6.  Respiratory syncytial virus infection in adults.

Authors:  A R Falsey; E E Walsh
Journal:  Clin Microbiol Rev       Date:  2000-07       Impact factor: 26.132

7.  Assessment of markers of the cell-mediated immune response after influenza virus infection in frail older adults.

Authors:  J E McElhaney; S Gravenstein; P Krause; J W Hooton; C M Upshaw; P Drinka
Journal:  Clin Diagn Lab Immunol       Date:  1998-11

8.  How complete is influenza immunization coverage? A study in 75 nursing and residential homes for elderly people.

Authors:  M R Evans; E J Wilkinson
Journal:  Br J Gen Pract       Date:  1995-08       Impact factor: 5.386

9.  Development and application of an enzyme immunoassay for coronavirus OC43 antibody in acute respiratory illness.

Authors:  E P Gill; E A Dominguez; S B Greenberg; R L Atmar; B G Hogue; B D Baxter; R B Couch
Journal:  J Clin Microbiol       Date:  1994-10       Impact factor: 5.948

10.  Long-term care facilities: a cornucopia of viral pathogens.

Authors:  Ann R Falsey; Gerard E Dallal; Maria A Formica; Gloria G Andolina; Davidson H Hamer; Lynette L Leka; Simin Nikbin Meydani
Journal:  J Am Geriatr Soc       Date:  2008-06-28       Impact factor: 5.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.